Advance research of histone deacetylase inhibitors in treatment of prostate cancer / 国际外科学杂志
International Journal of Surgery
;
(12): 28-30, 2011.
Artículo
en Chino
| WPRIM
| ID: wpr-381500
ABSTRACT
The imbalance between histone acetylation and histone deacetylation can lead to the inactivation of suppressor genes and the activation of oncogenes by influencing transcription. Based on this, researchers found that HDAC inhibitors can induce prostate cancer cells growth arrest, differentiation and apoptosis. This review summarizes the advance research of histone deacetylase inhibitors in treatment of prostate cancer.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
International Journal of Surgery
Año:
2011
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS